Chorea is the most common movement disorder associated to autoimmune diseases and one of the first non thrombotic neurological complications associated with antiphospholipid antibodies (aPL). Several treatment options have been considered, especially in young patients that failed to respond to conventional therapy. In the last years Intravenous immunoglobulin treatment (IVIG) are largely administered with beneficial and rapid effect not only in adult patients affected by autoimmune diseases, but also in children. IVIG treatment could be considered as therapeutic option also in children with antiphospholipid related chorea.

Brogna, C., Mariotti, P., Manna, R., Conventional and intravenous immunoglobulin therapy in paediatric antiphospholipid antibodies-related chorea, <<LUPUS>>, 2014; 23 (14): 1449-1451. [doi:10.1177/0961203314551084] [http://hdl.handle.net/10807/122823]

Conventional and intravenous immunoglobulin therapy in paediatric antiphospholipid antibodies-related chorea

Brogna, Claudia
Primo
;
Mariotti, Paolo;Manna, Raffaele
Ultimo
2014

Abstract

Chorea is the most common movement disorder associated to autoimmune diseases and one of the first non thrombotic neurological complications associated with antiphospholipid antibodies (aPL). Several treatment options have been considered, especially in young patients that failed to respond to conventional therapy. In the last years Intravenous immunoglobulin treatment (IVIG) are largely administered with beneficial and rapid effect not only in adult patients affected by autoimmune diseases, but also in children. IVIG treatment could be considered as therapeutic option also in children with antiphospholipid related chorea.
2014
Inglese
Brogna, C., Mariotti, P., Manna, R., Conventional and intravenous immunoglobulin therapy in paediatric antiphospholipid antibodies-related chorea, <<LUPUS>>, 2014; 23 (14): 1449-1451. [doi:10.1177/0961203314551084] [http://hdl.handle.net/10807/122823]
File in questo prodotto:
File Dimensione Formato  
editoriale lupus.pdf

accesso aperto

Dimensione 66.27 kB
Formato Adobe PDF
66.27 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/122823
Citazioni
  • ???jsp.display-item.citation.pmc??? 4
  • Scopus 14
  • ???jsp.display-item.citation.isi??? 13
social impact